Cited by 436Cardiovascular Function and Risk FactorsCardiomyopathy and Myosin StudiesGout, Hyperuricemia, Uric Acid

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy

Cappola, Thomas P., Kass, David A., Nelson, Gregory S., Berger, Ronald D., Rosas, Gisele O., Kobeissi, Zoulficar A., Marbán, Eduardo, Hare, Joshua M.·2001·Circulation

DOI 10.1161/hc4501.098928

Open this paper in CoChat — free account

Abstract

Background Dilated cardiomyopathy is characterized by an imbalance between left ventricular performance and myocardial energy consumption. Experimental models suggest that oxidative stress resulting from increased xanthine oxidase (XO) activity contributes to this imbalance. Accordingly, we hypothesized that XO inhibition with intracoronary allopurinol improves left ventricular efficiency in patients with idiopathic dilated cardiomyopathy. Methods and Results Patients (n=9; ejection fraction, 29±3%) were instrumented to assess myocardial oxygen consumption (MV̇ o 2 ), peak rate of rise of left ventricular pressure (dP/dt max ), stroke work (SW), and efficiency (dP/dt max /MV̇ o 2 and SW/MV̇ o 2 ) at baseline and after sequential infusions of intracoronary allopurinol (0.5, 1.0, and 1.5 mg/min, each for 15 minutes). Allopurinol caused a significant decrease in MV̇ o 2 (peak effect, −16±5%; P <0.01; n=9) with no parallel decrease in dP/dt max or SW and no change in ventricular load. The net result was a substantial improvement in myocardial efficiency (peak effects: dP/dt max /MV̇ o 2 , 22±9%, n=9; SW/MV̇ o 2 , 40±17%, n=6; both P <0.05). These effects were apparent despite concomitant treatment with standard heart failure therapy, including ACE inhibitors and β-blockers. XO and its parent enzyme xanthine dehydrogenase were more abundant in failing explanted human myocardium on immunoblot. Conclusions These findings indicate that XO activity may contribute to abnormal energy metabolism in human cardiomyopathy. By reversing the energetic inefficiency of the failing heart, pharmacological XO inhibition represents a potential novel therapeutic strategy for the treatment of human heart failure.

Integrity signals

Registry

Crossref · 10.1161/hc4501.098928

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Oxygen-Derived Free Radicals in Postischemic Tissue Injury
Epstein, F. H., & McCord, J. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120305 · Cited by 5,399
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.
Doucette, J. W., Corl, P. D., Payne, H. M., Flynn, A. E., Goto, M., Nassí, M., & Segal, J. (1992) · Circulation · doi:10.1161/01.cir.85.5.1899 · Cited by 1,017
Activation of the Cardiac Calcium Release Channel (Ryanodine Receptor) by Poly-S-Nitrosylation
Xu, L., Eu, J. P., Meissner, G., & Stamler, J. S. (1998) · Science · doi:10.1126/science.279.5348.234 · Cited by 991
Effective arterial elastance as index of arterial vascular load in humans.
Kelly, R. P., Ting, C.-T., Yang, T. M., Liu, C. P., Maughan, W. L., Chang, M.-S., & Kass, D. A. (1992) · Circulation · doi:10.1161/01.cir.86.2.513 · Cited by 832
Self-citation
Ventricular energetics
Suga, H. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.247 · Cited by 744
Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: Structure-based mechanism of conversion
Enroth, C., Eger, B. T., Okamoto, K., Nishino, T., Nishino, T., & Pai, E. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10723 · Cited by 733
A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure
Cohn, J. N., Goldstein, S., Greenberg, B., Lorell, B. H., Bourge, R. C., Jaski, B. E., Gottlieb, S. O., McGrew, F. A., DeMets, D. L., & White, B. G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392503 · Cited by 612
Increased Oxidative Stress in Patients With Congestive Heart Failure 11This study was supported by a grant jointly sponsored by the Medical Research Council of Canada, Ottawa and Bayer Pharmaceuticals, Etobicoke, Ontario, Canada.
Keith, M. E., Geranmayegan, A., Sole, M. J., Kurian, R., Robinson, A., Omran, A., & Jeejeebhoy, K. N. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00101-6 · Cited by 560
Elevated Levels of 8-iso-Prostaglandin F2αin Pericardial Fluid of Patients With Heart Failure
Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J., & Tedgui, A. (1998) · Circulation · doi:10.1161/01.cir.97.16.1536 · Cited by 458
Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols.
Campbell, D. L., Stamler, J. S., & Strauss, H. C. (1996) · The Journal of general physiology · doi:10.1085/jgp.108.4.277 · Cited by 441

Show all 31 references

Research works printed but not linked: 9

10.1161/circ.93.5.932 · DOI
10.1161/circ.97.16.1536 · DOI
10.1161/res.83.4.423 · DOI
10.1161/res.85.5.437 · DOI
10.1161/circ.103.5.750 · DOI
10.1161/circ.92.8.2198 · DOI
10.1161/circ.94.10.2497 · DOI
10.1161/circ.97.4.363 · DOI
10.1161/circ.103.6.826 · DOI

Sorted by citations

Items 301–400 of 436

Pathophysiology of heart failure and an overview of therapies
Ranek, M. J., Berthiaume, J. M., Kirk, J. A., Lyon, R. C., Sheikh, F., Jensen, B. C., Hoit, B. D., BUTANY, J. W., Tolend, M., Rao, V. A., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822224-9.00025-6 · Cited by 14
Allopurinol for Secondary Prevention in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Ye, Y., Liao, G., Liu, T., Hu, X., Chen, X., Bai, L., & Peng, Y. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10090379 · Cited by 12
Use of Diuretics in the Treatment of Heart Failure in the Elderly
Sica, D. A., Gehr, T. W. B., & Frishman, W. H. (2007) · Heart Failure Clinics · doi:10.1016/j.hfc.2007.07.009 · Cited by 12
The Oxidative Balance Orchestrates the Main Keystones of the Functional Activity of Cardiomyocytes
Bevere, M., Morabito, C., Mariggiò, M. A., & Guarnieri, S. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7714542 · Cited by 13
Preservation of cardiac contractility after long-term therapy with oxypurinol in post-ischemic heart failure in mice
Tan, Z., Dai, T., Zhong, X., Tian, Y., Leppo, M. K., & Gao, W. D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.033 · Cited by 11
Use of Diuretics in the Treatment of Heart Failure in the Elderly
Sica, D. A., Gehr, T. W. B., & Frishman, W. H. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2006.08.006 · Cited by 11
Serum uric acid to eGFR ratio correlates with adverse outcomes in elderly hospitalized for acute heart failure
Piani, F., Baschino, S., Agnoletti, D., Calandrini, L., Esposti, D. D., Micoli, A. D., Falcone, R., Fiorini, G., Ianniello, E., Mauloni, P. A., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132160 · Cited by 10
Therapeutic effects of allopurinol on the function of left ventricular and activity of matrix metalloproteinase enzymes (MMPs) in patients with chronic heart failure
Deng, H., Li, Q., & Zhu, D. (2022) · Cellular and Molecular Biology · doi:10.14715/cmb/2022.68.5.13 · Cited by 10
Ventricular dyssynchrony and mechanisms of resynchronization therapy
Kass, D. A. (2002) · European Heart Journal Supplements · doi:10.1093/ehjsupp/4.suppl_d.d23 · Cited by 10
Self-citation
Reactive Oxygen Species (ROS) Signaling in Cardiac Remodeling and Failure
Harvey, A., & Grieve, D. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_50 · Cited by 9
Pathophysiology of Heart Failure and an Overview of Therapies
Berthiaume, J. M., Kirk, J. A., Ranek, M. J., Lyon, R. C., Sheikh, F., Jensen, B. C., Hoit, B. D., BUTANY, J. W., Tolend, M., Rao, V. A., et al. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420219-1.00008-2 · Cited by 12
Serum uric acid as a novel marker for uterine atony and post-spinal vasopressor use during cesarean delivery
Kovacheva, V., Soens, M., & Tsen, L. C. (2013) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2013.04.005 · Cited by 9
Cardiac resynchronization therapy in heart failure: recent advances and new insights.
Bhatia, V., Bhatia, R., Dhindsa, S., & Virk, A. (2003) · PubMed · Cited by 9
Entrevista a Boaventura de Sousa Santos
Santos, B. D. S., & Granovsky, M. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 9
Febuxostat therapy improved the outcomes of cardiorenal syndrome rodent through alleviating xanthine oxidase-induced oxidative stress and mitochondrial dysfunction
Yang, C., Yue, Y., Chen, Y.-L., Chiang, J. Y., Wang, Y.-T., Huang, C., Cheng, B., Hsu, T., & Yip, H. (2025) · International Journal of Biological Sciences · doi:10.7150/ijbs.99194 · Cited by 8
The involvement of soluble epoxide hydrolase in the development of cardiovascular diseases through epoxyeicosatrienoic acids
Jiang, S., Han, S., & Wang, D. W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1358256 · Cited by 8
Use of Diuretics in the Treatment of Heart Failure in Older Adults
Sica, D. A., Gehr, T. W. B., & Frishman, W. H. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.02.006 · Cited by 8
DPP9 as a Potential Novel Mediator in Gastrointestinal Virus Infection
del Castillo-Izquierdo, Á., Moreno‐Navarrete, J. M., Latorre, J., Arnoriaga‐Rodríguez, M., Ballanti, M., Monteleone, G., Paoluzi, O. A., Mingrone, G., Puig, J., Ramos, R., et al. (2022) · Antioxidants · doi:10.3390/antiox11112177 · Cited by 8
Reactive Oxygen Species and Muscular Dystrophy
Matecki, S., Fauconnier, J., & Lacampagne, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_136 · Cited by 7
Nitric oxide and related factors linked to oxidation and inflammation as possible biomarkers of heart failure
Bonafede, R. J., & Manucha, W. A. (2018) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2017.12.003 · Cited by 7
Uric acid as a cardiorenal mediator: pathogenesis and mechanistic insights
Gulab, A., Torres, R., Pelayo, J., Lo, K. B., Shahzad, A., Pradhan, S., & Rangaswami, J. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.1941873 · Cited by 7
Biomarkers
Florea, V. G., & Anand, I. S. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.11.005 · Cited by 7
[Oxidative stress and heart failure].
Kinugawa, S., & Tsutsui, H. (2006) · PubMed · Cited by 7
Ventricular dyssynchrony and mechanisms of resynchronization therapy
KASS, D. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90157-4 · Cited by 7
Self-citation
Characterization of signaling mechanisms regulating cardiac contractility
Kubin, A. (2011) · Cited by 7
RNA Therapeutics in Heart Failure
Deiman, F. E., de Graaf, M. M., Silljé, H. H. W., Beverborg, N. G., Bömer, N., & van der Meer, P. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10717-9 · Cited by 6
Efectos del óxido nítrico sobre la función cardíaca
Tamargo, J. L., Caballero, R., Gómez, R. J., Núñez, L., Vaquero, M., & Delpón, E. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)74816-6 · Cited by 6
Valor pronóstico de la hiperuricemia en la insuficiencia cardíaca crónica
Alejandro Martínez, S., Alejandro González, M., Cristián Cerda, D., Pedro Pérez, C., Pablo Castro, G., Pérez, O., Rodrigo Isa, P., & Ramón Corbalán, H. (2004) · Revista médica de Chile · doi:10.4067/s0034-98872004000900002 · Cited by 6
Electrochemical investigation of allopurinol polymerised carbon paste electrode interface for epinephrine and folic acid sensing in pharmaceutical samples
Teradale, A. B., Ganesh, P., Lamani, S. D., Swamy, B. E. K., & Das, S. N. (2021) · Materials Research Innovations · doi:10.1080/14328917.2021.1975988 · Cited by 5
Phenotype-Based Classification of Obstructive Hypertrophic Cardiomyopathy Undergoing Myectomy
Cui, H. Z., Nie, H., Wang, C., Zhang, N., Wang, Y., Liu, W., Huang, S., Cheng, X. J., Jia, H., Shu, S., et al. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.12.016 · Cited by 5
Relation between prognostic impact of hyperuricemia and sympathetic overactivation in patients with heart failure
Joho, S., Ushijima, R., Nakagaito, M., & Kinugawa, K. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.08.008 · Cited by 5
Clinical Implication of Plasma Uric Acid Level
Shin, Y. T., Kim, K. K., & Hwang, I. C. (2009) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2009.30.9.670 · Cited by 5
CVT-4325 Inhibits Myocardial Fatty Acid Uptake and Improves Left Ventricular Systolic Function without Increasing Myocardial Oxygen Consumption in Dogs with Chronic Heart Failure
Imai, M., Rastogi, S., Sharma, N., Chandler, M. P., Sharov, V. G., Blackburn, B. K., Belardinelli, L., Stanley, W. C., & Sabbah, H. N. (2006) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-006-0496-5 · Cited by 5
4-Amino-6-hydroxypyrazolo [3,4-d]pyrimidine (AHPP) conjugated PEG micelles: Water soluble polymeric xanthine oxidase inhibitor
Bharate, G. Y., Fang, J. Q., Nakamura, H., Qin, H., Shinkai, S., & Maeda, H. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2011.633260 · Cited by 5
Activation of the Renin-Angiotensin System in Heart Failure
Kumar, R., Baker, K. M., & Pan, J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10009-9 · Cited by 5
Mechanisms of cardioprotection resulting from Brown Norway chromosome 16 substitution in the salt-sensitive Dahl rat
Kriegel, A. J., Didier, D. N., Li, P., Lazar, J., & Greene, A. S. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00175.2011 · Cited by 4
Ghrelin mediated cardioprotection using in vitro models of oxidative stress
Kok, C., Ghossein, G., Igoor, S., Rao, R., Titus, T., Tsurusaki, S., Chong, J. J. H., & Kizana, E. (2024) · Gene Therapy · doi:10.1038/s41434-023-00435-9 · Cited by 4
Xanthine Oxidase Inhibitor Treatment of Hyperuricemia
Dalbeth, N., & Stamp, L. K. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2864-4.10013-2 · Cited by 4
Temas de actualidad en insuficiencia cardiaca
Colet, J. C., Aguilera, R. M., Castillo, J. J. C., & Delgado, J. F. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70044-2 · Cited by 4
Therapeutic patents for chronic heart failure: a review of patent applications from 1996 to 2002
Anker, S. D., Jankowska, E. A., & Okonko, D. O. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.5.639 · Cited by 4
Cardiac remodelling: General aspects and mechanisms
Pontes, H. B. D., & Pontes, J. C. D. V. (2016) · Current research. Cardiology · doi:10.4172/2368-0512.1000073 · Cited by 4
Acute and Chronic Endothelial Dysfunction: Implications for the Development of Heart Failure
Linke, A., Recchia, F. A., Zhang, X.-P. S., & Hintze, T. H. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7960-5_9 · Cited by 4
Hyperuricaemia elevates risk of short-term readmission and mortality in patients with heart failure
Rao, J., Lai, R., Jiang, L., Wen, W. X., & Chen, H. (2024) · Open Heart · doi:10.1136/openhrt-2024-002830 · Cited by 3
Heart Mitochondria: A Receiver and Integrator of Signals
Marı́n-Garcı́a, J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9461-5_8 · Cited by 3
Post-Genomics Cardiovascular Signaling Pathways
Marı́n-Garcı́a, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00003-2 · Cited by 3
Uric Acid Level is Positively Associated With NT-proBNP Concentration in Slovak Heart Failure Patients
Sabaka, P., Dukát, A., Gajdošík, J., Čaprnda, M., Bendžala, M., & Šimko, F. (2019) · Physiological Research · doi:10.33549/physiolres.934186 · Cited by 3
The adverse effect of metabolic syndrome on left ventricular global strains and myocardial energetic efficiency in non-ischemic dilated cardiomyopathy patients: a cardiac magnetic resonance study
Shen, M., Li, Y., Shi, K., Wang, J., Li, J., Jiang, Y., Gao, Y., Yu, S., Li, X., Yan, W., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02690-z · Cited by 3
High-Dose Prednisone in Patients With Heart Failure and Hyperuricemia: Friend and Foe?
de Denus, S., & Rouleau, J. L. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.01.007 · Cited by 3
Insulin resistance and depressed cardiac G6PD activity induced by glucocorticoid exposure during pregnancy are attenuated by maternal estrogen-progestin therapy
Badmus, O. O., Anoka, N. A., Ologe, M. O., & Olatunji, L. A. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103423 · Cited by 3
Oxidase Interactions in Cardiovascular Disease
Youn, J. Y., Siu, K. L., Li, Q., Harrison, D. G., & Cai, H. “. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_43 · Cited by 3
Cardiovascular Signaling Pathways
Marı́n-Garcı́a, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50005-x · Cited by 3
Uric Acid and Left Ventricular Hypertrophy
Saitoh, S. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0092 · Cited by 3
MEDICINE AND PSYCHOLOGY: MODERN PROBLEMS, NEW TECHNOLOGIES AND WAYS OF DEVELOPING OUTDATED THEORIES
Vladlenov, D., Mezhiievska, I. A., Maslovskyi, V., Pavlov, S. V., Razmadze, M., Samkharadze, R., Gachechiladze, L., Razmadze, D., Тащук, В. К., Khrebtii, H. I., et al. (2024) · Іnternational Science Group eBooks · doi:10.46299/isg.2024.mono.med.1 · Cited by 2
Xanthine oxidase inhibitor allopurinol preserves cardiac function after experimental malocclusion induced by occlusal disharmony in mice
Mitsubayashi, T., Suita, K., Ohnuki, Y., Ishikawa, M., Ito, A., Matsuo, I., Miyamoto, G., Abe, M., Morii, A., Mototani, Y., et al. (2025) · The Journal of Physiological Sciences · doi:10.1016/j.jphyss.2025.100029 · Cited by 3
Increased QT Dispersion and High Risk of Ventricular Arrhythmias is Associated with Hyperuricemia in Individuals with Normal Renal Function
Huddam, B., Alp, A., Genek, D. G., Azak, A., & Karakuş, V. (2021) · Journal of Cardiovascular Emergencies · doi:10.2478/jce-2021-0011 · Cited by 2
The High-Risk Patient With Heart Failure With Reduced Ejection Fraction: Treatment Options and Challenges
Bartos, J. A., & Francis, G. S. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.137 · Cited by 3
Change of Plasma Xanthine Oxidase Activity by Intermittent Hepatic Ischemia-Reperfusion
Ha, S. J., Kim, J. H., Park, S.-S., Kim, I., Baek, W.-Y., & Lim, D. G. (2004) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2004.47.5.692 · Cited by 2
Low acid uric in primary prophylaxis: worthy?
Aloia, E., & Sciaccaluga, C. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.065 · Cited by 2
Evaluation of oxidant status in both systolic and diastolic heart failure
Asoğlu, R., Sezen, H., Erkuş, M. E., Altıparmak, H., Kaya, Z., Asoğlu, E., Günebakmaz, Ö., Demirbağ, R., & Sezen, Y. (2018) · Medical Science and Discovery · doi:10.17546/msd.458810 · Cited by 2
Exercise Training Improves Endothelial Function in Human Cardiovascular Disease – Role of Oxidative Stress
Winzer, E. B., & Linke, A. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_168 · Cited by 2
Role of Nitric Oxide in the Pathophysiology of Heart Failure
Champion, H. C., Skaf, M. W., & Hare, J. M. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7960-5_7 · Cited by 2
Self-citation
Cardiometabolic Phenotyping in Heart Failure: Differences between Patients with Reduced vs. Preserved Ejection Fraction
Balletti, A., Biase, N. D., Punta, L. D., Filidei, F., Armenia, S., Masi, F., Fiore, V. D., Mazzola, M., Bacca, A., Dini, F. L., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13040790 · Cited by 2
INNOVATIVE WAYS OF IMPROVING MEDICINE, PSYCHOLOGY AND BIOLOGY
Vladlenov, D., Khrebtii, H. I., Коваль, Г., Вакаров, О. С., Карбованець, О. І., Голомб, Л., Петросова, В. І., Руснак, І., Кулачек, В., Кулачек, Я., et al. (2023) · Іnternational Science Group eBooks · doi:10.46299/isg.2023.mono.med.2 · Cited by 5
MODERN TECHNOLOGIES AND PROCESSES OF IMPLEMENTATION OF NEW METHODS
International Science Group, & Vladlenov, D. (2024) · doi:10.46299/isg.p.2024.1.5 · Cited by 2
Cardiac Ischemia and Reperfusion
Velayutham, M., & Zweier, J. L. (2013) · Wiley eBooks · doi:10.1002/9781118355886.ch11 · Cited by 3
Xanthine Oxidase Inhibitors and Insulin Sensitizers
Doehner, W. (2005) · CRC Press eBooks · doi:10.1201/9780849333798.ch25 · Cited by 2
Diet modulates cardiac metabolic stress during anthracycline treatment
Kim, K., Gao, Y., Shankar, T., & Karlstaedt, A. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00745.2025 · Cited by 1
Emerging therapeutic directions for inotropic therapy in heart failure
Pironti, G., Maack, C., Andersson, D. C., & Lund, L. H. (2026) · Med · doi:10.1016/j.medj.2026.101073 · Cited by 1
Intracellular mitochondrial-subcellular communication: A regulator of myocardial energy metabolic homeostasis in heart failure
Kang, Y., Sun, X.-T., Li, A.-L., Zhang, A., Fan, X., Shang, W.-Y., Jia, Y., Zhao, Y.-X., Miao-miao, W., Cao, Y.-X., et al. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103192 · Cited by 1
Febuxostat, ein neues Pharmakon zur Behandlung der Gicht
Christalla, P., Wittköpper, K., & El‐Armouche, A. (2011) · Der Kardiologe · doi:10.1007/s12181-010-0320-0 · Cited by 1
Something Old Holds Potential to Be Something New in Heart Failure: Allopurinol Revisited
Jaswal, J. S., Ussher, J. R., Lopaschuk, G. D., & Johnstone, D. E. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.001 · Cited by 1
Uric Acid as a Predictor of All-Cause Mortality in Heart Failure:
Meta-Analysis, A. (2011) · Cited by 1
Serum Uric Acid Levels: A Potential Biomarker for the Acute Myocardial Infarction in Hypertensive Patients
Rodrigues, F. S. M., de Paula, L., Errante, P. R., Caricati Neto, A., & Bergantin, L. B. (2017) · Journal of Thrombosis and Circulation Open Access · doi:10.4172/2572-9462.1000e107 · Cited by 1
Klinische Relevanz des Energiestoffwechsels im Herzen
Deußen, A. (2017) · Zeitschrift für Herz- Thorax- und Gefäßchirurgie · doi:10.1007/s00398-017-0178-6 · Cited by 1
Oxidative and Nitrosative Stress in Heart Failure
Sawyer, D. B., Liang, C., & Colucci, W. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10012-9 · Cited by 1
The effects of Allopurinol on levels of cardiac troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial
Khiali, S., Sarbakhsh, P., Mashayekhi, S., Mohamadrezapour, E., Dousti, S., & Entezari‐Maleki, T. (2021) · Pharmaceutical Sciences · doi:10.34172/ps.2021.14 · Cited by 1
Potential New Drug Targets Modulating the Environmentally-Induced Oxidative Stress in the Cardiovascular System
Đurašević, S., Zdravkovic, M. D., Nikolić, V., & Todorović, Z. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-62806-1_21 · Cited by 1
Allopurinol attenuates development of Porphyromonas gingivalis LPS-induced cardiomyopathy in mice
Morii, A., Matsuo, I., Suita, K., Ohnuki, Y., Ishikawa, M., Ito, A., Miyamoto, G., Abe, M., Mitsubayashi, T., Mototani, Y., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318008 · Cited by 2
Signaling Cascades in Heart Failure: From Cardiomyocytes Growth and Survival to Mitochondrial Signaling Pathways
Marı́n-Garcı́a, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-147-9_7 · Cited by 1
Oxidative Stress in Heart Failure
Sverdlov, A. L., Ngo, D. T. M., & Colucci, W. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00008-9 · Cited by 1
Oxidative Stress in Heart Failure
Sawyer, D. B., & Colucci, W. S. (2006) · Developments in cardiovascular medicine · doi:10.1007/0-387-29553-4_18 · Cited by 1
Terapia eléctrica en la insuficiencia cardíaca
Bichara, V. M. (2009) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1
Allopurinol and heart failure: A new use for an old drug?
Prabhu, S. D. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.05.011 · Cited by 1
Biomarkers in Acute Heart Failure: From Risk Markers to Therapeutic Targets
Kalogeropoulos, A. P., Georgiopoulou, V. V., & Butler, J. (2012) · Congestive Heart Failure · doi:10.1111/chf.12019 · Cited by 1
A renaissance of positive inotropic interventions to treat heart failure?
Neumann, J. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00557-1 · Cited by 1
New Approaches to the Treatment of Heart Failure
Givertz, M. M., & Colucci, W. S. (2002) · doi:10.1007/978-1-4615-6490-4_13 · Cited by 1
Effects of xanthine oxidase inhibitors in pulmonary hypertension associated with chronic lung disease
Liu-Shiu-Cheong, P. S. (2019) · Cited by 1
Lipoproteins and Hyperlipoproteinemia: Links to Gout
Hsu, T. C. (2012) · Otago University Research Archive (University of Otago)
Biophysics of Membrane Currents in Heart Failure
Liu, M., Brahmanandam, V., & Dudley, S. C. (2013) · Biological and medical physics series · doi:10.1007/978-1-4614-7678-8_4
Quellen und Effekte reaktiver Sauerstoffspezies in Herzmuskelzellen
Cura, A. A. (2014) · Publications of the UdS (Saarland University) · doi:10.22028/d291-21986
Papel del estrés oxidativo y nitrosativo en la hipertrofia cardiaca y remodelación ventricular
Giraldo, A. (2019) · Acta Médica Colombiana · doi:10.36104/amc.2010.1570
Oxidative Stress and Redox Signalling in Cardiac Remodelling
Zhang, M., Sirker, A., & Shah, A. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-600-9_21
Relationship of Oxidative Stress with Cardiovascular Disease
White, R. E., Barman, S. A., Zhu, S., & Han, G. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-041-0_15
Correlation of docking energies with spectroscopic kinetic assays of potential xanthine oxidase substrates
Stockert, A., Mahfouz, T. M., Petersen, B., & Fakunmoju, O. L. (2013) · Journal of Biophysical Chemistry · doi:10.4236/jbpc.2013.41003
Effects of allopurinol on ventricular ejection fraction in patients with left ventricular failure
Garakyraghi, M., Hadizadeh, M., Hadizadeh, F., Neshatdoust, B., & Sadeghi, M. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)
Heart Mitochondrial ROS and Oxidative Stress
Marı́n-Garcı́a, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4599-9_10
Is Allopurinol a Potential New Treatment for Angina pectoris?
Higgins, P., Walters, M. R., & Dawson, J. (2010) · Future Cardiology · doi:10.2217/fca.10.88
Allopurinol for fetal neuro- and cardiovascular protection
Kaandorp, J. J. (2014) · Utrecht University Repository (Utrecht University)
Mendelian Randomisation: Inferring the causal relationship between urate and associated biochemical and phenotypic parameters.
Hughes, K. B. (2013) · Otago University Research Archive (University of Otago)
Allopurinol regresses left ventricular hypertrophy in patients with type 2 diabetes
Szwejkowski, B. R. (2014)

Authors: Cappola, T. P., Kass, D. A., Nelson, G. S., Berger, R. D., Rosas, G. O., Kobeissi, Z. A., Marbán, E., & Hare, J. M.
Affiliations: Johns Hopkins University (US)
From the Department of Medicine, Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Md.
ORCID: Cappola, Thomas P.
Kass, David A.
Berger, Ronald D.
Hare, Joshua M.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2001-11-13
Volume: 104
Issue: 20
Pages: 2407-2411
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/hc4501.098928
OpenAlex: W2129194977
Cited by: 436
References: 31
Citations by year: 2026: 3 · 2025: 9 · 2024: 12 · 2023: 7 · 2022: 12 · 2021: 14 · 2020: 17 · 2019: 12 · 2018: 12 · 2017: 17 · 2016: 12 · 2015: 17 · 2014: 21 · 2013: 27 · 2012: 25
FWCI: 11.93
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: Johns Hopkins University
National Institutes of Health
National Heart, Lung, and Blood Institute (K08HL003238, K08-HL-03238, R01 HL65455, R01HL065455)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
Keywords: allopurinol, idiopathic dilated cardiomyopathy, xanthine oxidase inhibition, myocardial energy metabolism, myocardial oxygen consumption, stroke work, heart failure treatment, xanthine dehydrogenase, oxidative stress
MeSH terms: Allopurinol, Cardiomyopathy, Dilated, Enzyme Inhibitors, Female, Hemodynamics, Humans, Male, Middle Aged, Myocardial Contraction, Myocardium, Oxygen Consumption, Xanthine Oxidase, Oxidative Stress, Ventricular Dysfunction, Left

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks